Bastide Le Confort Médical SA (EPA:BLC)
France · Delayed Price · Currency is EUR 22.60
-0.15 (-0.66%)
Sep 11, 2026, 5:35 PM CET
EPA:BLC Market Cap
EPA:BLC has a market cap or net worth of €167.51 million as of September 11, 2026. Its market cap has decreased by -6.51% in one year.
Market Cap
167.51M
Enterprise Value
465.87M
Revenue
510.46M
Ranking
n/a
PE Ratio
18.70
Stock Price
€22.60
ChartMarket Cap Chart
Since May 22, 1997, EPA:BLC's market cap has increased from 10.73M to 167.51M, an increase of 1,461.02%. That is a compound annual growth rate of 9.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 167.51M | -4.52% |
| Dec 31, 2025 | 175.44M | -0.18% |
| Dec 31, 2024 | 175.75M | -10.17% |
| Dec 29, 2023 | 195.66M | -27.00% |
| Dec 30, 2022 | 268.04M | -18.51% |
| Dec 31, 2021 | 328.91M | -11.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 88.94B |
| EssilorLuxottica Société anonyme | 68.48B |
| Sartorius Stedim Biotech | 18.54B |
| Ipsen | 13.00B |
| Transgene | 241.29M |
| Eurobio Scientific Société anonyme | 200.86M |
| Cellectis | 199.19M |
| Innate Pharma | 155.72M |